✦ LIBER ✦

Rapamycin-based and late FK506-light immunosuppression in heart transplant recipients

✍ Scribed by B.P Griffith; S.M Augustine; C Wade; S.S Gottlieb; C DeFilippi; C Drachenberg; R Poston; J Gammie; J.M Brown; R.N Pierson III

Book ID: 117710296
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 60 KB
Volume: 22
Category: Article
ISSN: 1557-3117
DOI: 10.1016/s1053-2498(02)00832-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunosuppression switch in pediatric he

Immunosuppression switch in pediatric heart transplant recipients: Cyclosporine to FK 506

✍ Jeanine M. Swenson; F. Jay Fricker; John M. Armitage 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 553 KB

Safety and Efficacy of Late Conversion t

Safety and Efficacy of Late Conversion to Sirolimus Based Immunosuppression, in Heart Transplant Recipients

✍ B. Kamoga Gilbert-Roy; Sherry LaForest; Parag Kale; James Fang 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Occurrence of gammopathies and lymphopro

Occurrence of gammopathies and lymphoproliferative disorders in liver transplant recipients randomized to tacrolimus (FK506)- or cyclosporine-based immunosuppression

✍ Pham, Hung ;Lemoine, Antoinette ;Salvucci, Marina ;Azoulay, Daniel ;Frenoy, Nico 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 110 KB

Lymphoproliferative disorders (LPDs) are a serious side effect of immunosuppression after liver transplantation, and the introduction on the market of a new immunosuppressive drug has been associated with an increased risk of these disorders. To compare the effect of cyclosporine A (CSA) and FK506 i

Predictors and outcome of early- versus

Predictors and outcome of early- versus late-onset major bacterial infections in liver transplant recipients receiving tacrolimus (FK506) as primary immunosuppression

✍ N. Singh; T. Gayowski; M. M. Wagener; I. R. Marino 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 613 KB

Influence of Everolimus-Based Immunosupp

Influence of Everolimus-Based Immunosuppression on Infections in Heart Transplant Recipients

✍ Ohdah, S.; Meyer, S.; Schlüter, M.; Deuse, T.; Müllerleile, K.; Reichenspurner, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Comparison of FK-506, Rapamycin, Ascomyc

Comparison of FK-506, Rapamycin, Ascomycin, and Cyclosporine in Mouse Models of Host-versus-Graft Disease and Heterotopic Heart Transplantation

✍ K. W. MOLLISON; T. A. FEY; R. A. KRAUSE; V. A. THOMAS; A. P. MEHTA; J. R. LULY 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB